Sponsor Check › Person
Named as an officer, director or promoter on SEC Form D filings · CA · Dec 7, 2009 → Dec 10, 2025
Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:15 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET
George Lee is listed as an executive officer, director, and promoter on 16 SEC Form D filings by 9 issuers between Dec 2009 and Dec 2025. Largest by amount reported sold: BlossomHill Therapeutics, Inc. (San Diego, CA — pharmaceuticals — 2021–2025; $88.6M reported sold to 47 investors), TP Therapeutics, Inc. (San Diego, CA — pharmaceuticals — 2017; $80M reported sold to 16 investors), Apexigen, Inc. (San Carlos, CA — biotechnology — 2013; $45.8M reported sold to 30 investors), Cardiva Medical, Inc. (Santa Clara, CA — other health care — 2017–2020; $45M reported sold to 59 investors), TP Therapeutics, Inc. (San Diego, CA — pharmaceuticals — 2016; $18M reported sold to 26 investors) and 4 more (all listed below).
What this means A repeat sponsor — 9 separate companies raised money with this person listed as executive officer, director, and promoter, over about 16 years. Across those companies the filings report $291.6M sold in total.
Listed alongside Bihua Chen (5 shared filings), Dean Tsao (4 shared filings), Yishan Li (4 shared filings), "Zonh-Zen ""Winston""" Ho (3 shared filings), Augustine Y. Lien (3 shared filings) and 29 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around George. Each name links to their own page.
The issuers belong to 2 sponsor groups: Tp Therapeutics (2 issuers, $98M reported sold, 2014–2018) and Apexigen (2 issuers, $51.4M reported sold, 2013–2023).
What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 4 court cases matching the name, 8 bankruptcy cases matching the name listed in Key records below.
What this means 12 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 16 public filings for George Lee and found 12 differences, 1 worth asking the sponsor about: 6 Form Ds were filed more than 15 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.
Community search for George Lee has not run yet — it is joining a line of 25,466 names; searches run around the clock at the hosts' allowed rate. Searched so far: 638 names.
Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).
Five things investors ask first. Items still in human review are counted, not shown.
4 cases: 2 closed (disposition not in docket feed), 1 judgment, 1 dismissed
890 Other Statutory Actions· Cause:
28:1331 Fed. Question
864 S.S.I.D.
890 Other statutory actions
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:15 AM ET.
Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.
State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: VA (crawled Oct 23, 2026)
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched George Lee..
State securities regulators: Securities regulators searched (3,318 actions): AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE DOJ Investor Protection Unit (257 actions, 1987–2026), TX State Securities Board (586 actions, 2006–2026), WA DFI (2,039 actions, 2001–2026) — last crawled Oct 23, 2026, 9:57 PM ET. No machine-readable public listing today for CO, FL, IA, IN, MN, NE, NJ, NY, OH, UT, VA (see docs/state-regulators.md).
8 cases: 8 closed (disposition not in docket feed)
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:15 AM ET.
Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.
State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons cover issuers and sponsor groups — see the issuer pages under Deals
12 differences found between the filings for George Lee — 1 worth asking about (compared 16 filings on Oct 24, 2026)
United States Bankruptcy Court, C.D. California docket "Bill B Brownell" filed Mar 12, 2012, closed Jul 9, 2012. Bill Brownell (listed on the same filings) is listed as Debtor ("Bill B Brownell"). Our match estimate: 70%.
What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.
United States Bankruptcy Court, S.D. California docket "AT&T Universal Card Services v. Stayner" filed Sep 10, 1996, closed Oct 17, 1997. Tony Stayner (listed on the same filings) is listed as Defendant ("Stayner"). Our match estimate: 70%.
What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.
CLOUD FINANCIAL INC (last filing Dec 7, 2009; $82,500 sold of $500,000). Each has no filing in more than two years and reported under half its target sold.
What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.
Form D filed 189 days after the first sale — RevMAb Biosciences, Inc. · Form D filed 570 days after the first sale — RevMAb Biosciences, Inc. · Form D filed 633 days after the first sale — Applied BioCode, Inc. · Form D filed 187 days after the first sale — TP Therapeutics, Inc. · Form D filed 432 days after the first sale — Applied BioCode, Inc. · and 1 more
What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.
No amendment in the last 12 months on an offering that may still be open — BlossomHill Therapeutics, Inc. (latest filing Jan 2, 2024) · No amendment in the last 12 months on an offering that may still be open — RevMAb Biosciences, Inc. (latest filing Feb 15, 2018) · No amendment in the last 12 months on an offering that may still be open — Cardiva Medical, Inc. (latest filing Jan 4, 2018) · No amendment in the last 12 months on an offering that may still be open — PastureMap Inc. (latest filing Nov 3, 2017) · No amendment in the last 12 months on an offering that may still be open — Applied BioCode, Inc. (latest filing Apr 8, 2016) · and 5 more
What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.
The Mar 24, 2017 filing says $44,234,211 offered; the Jan 4, 2018 Form D/A says $49,859,836.
What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.
listed as "George Lee" on 11 filings (from Dec 7, 2009), and "George J. Lee" on 5 filings (from Dec 5, 2012).
What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.
This page covers filings where the address state is CA. A separate record, "George Lee" with address state NY, is listed on 6 filings — most recently by Lee & Chen Capital LP (Aug 5, 2020). Both records have filings in the same period (Sep 23, 2014 to Aug 5, 2020).
What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.
This page covers filings where the address state is CA. A separate record, "George M. Lee" with address state TX, is listed on 4 filings — most recently by SWNB BANCORP INC (Feb 28, 2019). Both records have filings in the same period (May 4, 2010 to Feb 28, 2019).
What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.
This page covers filings where the address state is CA. A separate record, "George W. Lee, Jr." with address state NY, is listed on 1 filing — most recently by OP TECH ENVIRONMENTAL SERVICES INC (Nov 12, 2010). Both records have filings in the same period (Nov 12, 2010).
What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.
The people listed on the Apr 8, 2016 filing give Saratoga, CA; on the Feb 15, 2018 filing they give South San Francisco, CA.
What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.
The people listed on the Dec 5, 2012 filing give Santa Fe Springs, CA; on the Apr 8, 2016 filing they give Sante Fe Springs, CA.
What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.
What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.
None reported on 15 offerings — no sales commissions, finder's fees or proceeds to insiders
| Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it | Source |
|---|---|---|---|---|---|
| Dec 10, 2025 D BlossomHill Therapeutics, Inc. File 021-566357 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jan 2, 2024 D BlossomHill Therapeutics, Inc. File 021-501240 | $0 | $0 | $0 (est.) | None listed on this filing | EDGAR ↗ |
| Mar 1, 2021 D BlossomHill Therapeutics, Inc. File 021-390805 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jul 14, 2020 D Cardiva Medical, Inc. File 021-370917 | $0 | $0 | $0 (est.) Proceeds will be used for general corporate purposes. | None listed on this filing | EDGAR ↗ |
| Feb 15, 2018 D RevMAb Biosciences, Inc. File 021-305697 | $0 | $0 | $0 Officers and directors of the Company are paid salaries in the ordinary course of business and as authorized by the Board of Directors. | None listed on this filing | EDGAR ↗ |
| Jan 4, 2018 D/A Cardiva Medical, Inc. File 021-283285 | $0 | $0 | $0 (est.) Proceeds will be used for general corporate purposes. | None listed on this filing | EDGAR ↗ |
| Nov 3, 2017 D PastureMap Inc. File 021-298089 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| May 25, 2017 D TP Therapeutics, Inc. File 021-287476 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Apr 8, 2016 D Applied BioCode, Inc. File 021-260891 | $0 | $0 | $0 The persons named in Item 3 may receive payments deemed to be made from the proceeds of the offering, including salary. The amount of such salaries cannot be estimated at this time. | None listed on this filing | EDGAR ↗ |
| Apr 8, 2016 D RevMAb Biosciences, Inc. File 021-260908 | $0 | $0 | $0 The persons named in Item 3 may receive payments deemed to be made from the proceeds of the offering, including salary. The amount of such salaries cannot be estimated at this time. | None listed on this filing | EDGAR ↗ |
| Mar 21, 2016 D TP Therapeutics, Inc. File 021-259624 | $0 | $0 | $0 The persons named in Item 3 may receive payments deemed to be made from the proceeds of the offering, including salary. The amount of such salaries cannot be estimated at this time. | None listed on this filing | EDGAR ↗ |
| May 13, 2013 D Apexigen, Inc. File 021-196365 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Dec 5, 2012 D Applied BioCode, Inc. File 021-187883 | $0 | $0 | $0 (est.) Those persons who are employees or consultants of the Issuer are paid their respective salaries, wages or fees. | None listed on this filing | EDGAR ↗ |
| Dec 5, 2012 D Applied BioCode, Inc. File 021-187884 | $0 | $0 | $0 (est.) Those persons who are employees or consultants of the Issuer are paid their respective salaries, wages or fees. | None listed on this filing | EDGAR ↗ |
| Dec 7, 2009 D/A CLOUD FINANCIAL INC File 021-127197 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
Every issuer that named George Lee on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.
Raised $88.6M from 47 investors (100% of the $84.2M target) as of the latest filing. George is listed as director on 3 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $45M from 59 investors (100% of the $45M target) as of the latest filing. George is listed as director on 3 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $3.3M from 30 investors (55% of the $6M target) as of the latest filing. George is listed as director on 2 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $1.53M from 29 investors (77% of the $2M target) as of the latest filing. George is listed as executive officer, director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Agriculture / 506(b) (448 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $80M from 16 investors (100% of the $45M target) as of the latest filing. George is listed as director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $9.26M from 14 investors (77% of the $12M target) as of the latest filing. George is listed as director on 3 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $18M from 26 investors (100% of the $18M target) as of the latest filing. George is listed as director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $45.8M from 30 investors (100% of the $20M target) as of the latest filing. George is listed as director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
Raised $83K from 3 investors (17% of the $500K target) as of the latest filing. George is listed as executive officer, director, promoter.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.
Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.
Bihua Chen is on 30 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as George Lee. Their page shows their other deals.
Carl L. Gordon is on 62 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as George Lee. Their page shows their other deals.
Listed on the same filings as George Lee. Their page shows their other deals.
Matthew S. Crawford is on 9 issuers in total — a repeat sponsor. Their page lists every one.
Rick Anderson is on 12 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as George Lee. Their page shows their other deals.
One team, 2 deal companies. George Lee is listed on 2 of them.
Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name George Lee.
One team, 2 deal companies. George Lee is listed on 1 of them.
Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name George Lee.
A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.
None of the 9 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.
Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.
Property records are matched to companies only, never to individuals, so none are matched to George Lee by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 9 issuers this person is listed on — nothing matched.
Websites and social links of the issuers George Lee is listed on: none on file. No website or social profile named in BlossomHill Therapeutics, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #50,444 of 374,652 in line (1,289 issuers searched so far). One-tap searches: Look further ↓
One-tap searches on sites we do not index ourselves, with the name pre-filled (San Diego, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when George Lee appears on a new Form D, or when a court case or SEC action is matched to them. See plans →